| 产品名称 | Synthelis | PL067 | Glucagon-like peptide 1 receptor |
|---|---|
| 目录号 | PL067 |
| 别名 | GLP1R |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| PL067 | 10 µg, 50 µg, 100 µg | 咨询 | 咨询 |
Synthelis | PL067 | Glucagon-like peptide 1 receptor
品名：Glucagon-like peptide 1 receptor(GLP1R)
货号：PL067
规格：10 µg, 50 µg, 100 µg
品牌：Synthelis
产品描述
The glucagon-like peptide-1 receptor (GLP-1R) is a class B GPCR that is a major therapeutic target for the treatment of type 2 diabetes. The receptor is activated by the incretin peptide GLP-1 (Glucagon Like Peptide) promoting a broad range of physiological effects including glucose-dependent insulin secretion and biosynthesis, improved insulin sensitivity of peripheral tissues, preservation of β-cell mass and weight loss, all of which are beneficial in the treatment of type 2 diabetes.
| Protein | Glucagon-like peptide 1 receptor |
| Origin | Human |
| Format | Proteoliposome |
| Molecular weight | 55.5 kDa |
| Application | Drug screening & discovery, antibody development, structural biology |
